Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c

被引:76
作者
Ito, C [1 ]
Maeda, R [1 ]
Ishida, S [1 ]
Sasaki, H [1 ]
Harada, H [1 ]
机构
[1] Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Naka Ku, Hiroshima 7300052, Japan
关键词
correlation; FPG; 2-h PG; HbA1c;
D O I
10.1016/S0168-8227(00)00187-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A study was made on the association among 2-h plasma glucose (PG) in oral glucose tolerance test (OGTT), fasting plasma glucose (FPG)using correlation and regression equation. Subjects were 13 174 OGTT examinees tested between 1980 and 1948. Blood glucose was determined by the glucose oxidase method and glycated hemoglobin (HbA1c) by the HPLC method. As for correlation between 2-h PG and FPG, regression equation of the < 60 year group was y = 57.1 + 0.336x (r = 0.866, P < 0.0001) and that of the greater than or equal to 60 year group was y = 61.5 + 0.286 x (r = 0.814, P < 0.0001). FPG was calculated at 124.3 in the < 60 year group and 118.7 mg/dl in the greater than or equal to 60 year group for 2-h PG of 200 mg/dl, 2-h PG were calculated at 199.5 and 210.7 mg/dl for FPG of 126 mg/dl, respectively. In the < 60 year group, FPG were calculated at 121.7 and 124.4 mg/dl and 2-h PG at 193.2 and 199.3 mg/dl for HbA1c of 6.0 and 6.1%, respectively. As for associations between HbA1c and FPG or 2-h PG being high correlation, it is possible to estimate a prevalence of DM in a group using HbA1c <greater than or equal to> 6.1%. High correlations were demonstrated among all the three measures; FPG, 2-h PG, HbA1c. If 2-h PG is used in diagnosing diabetes mellitus, an FPG of 126 mg/dl proposed by ADA and World Health Organization (WHO) as a diagnostic level of FPG is an acceptable value for the Japanese. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 15 条
[11]  
PETER AL, 1996, JAMA-J AM MED ASSOC, V16, P1246
[12]   Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging [J].
Scheen, AJ ;
Sturis, J ;
Polonsky, KS ;
VanCauter, E .
DIABETOLOGIA, 1996, 39 (05) :564-572
[13]  
Shima K, 1998, J JPN DIABETES SOC, V41, P317
[14]  
SHIMAZU M, 1996, DIABETES CARE, P8
[15]  
*STEN DIAB CTR, 1999, DIABETOLOGIA, V42, P647